IP Library Patent Application 14776141
Patent Application
App. No. 14/776,141

METHODS OF SEQUENCING THE IMMUNE REPERTOIRE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/776,141
Abstract

The invention provides a non-invasive technique for the detection and quantification of the immune repertoire, in a biological sample containing a plurality of distinct cell populations. Methods are conducted using sequencing technology to detect and enumerate immune repertoire within a heterogeneous biological sample.

Claims (20)

1 . A method of determining the immune repertoire in a subject, comprising:

a. isolating a plurality of RNA from a biological sample comprising a plurality of cell types obtained from a subject,

b. producing immunoglobulin chain or TCR chain cDNAs from the RNA;

c. adding a homopolymeric tail, a random molecular tag and a universal sequence to the 3′ end of the cDNAs;

d. amplifying the cDNAs by using a one or more immunoglobulin chain or TCR chain specific primers and a universal sequence specific primer comprising an flanking sequence specific to the sequencing platform to produce a plurality of molecular tagged immunoglobulin chain or TCR chain nucleic acids;

e. sequencing the amplified immunoglobuling chain or TCR chain nucleic acids to produce a plurality of sequencing reads thereby determining the immune repertoire of the subject.

2 . The method of claim 1 , further comprising a data analysis step after step (e).

3 . The method of claim 2 , wherein the data analysis includes grouping sequences reads with the same molecular tag and clustering sequences within the same group.

4 . The method of claim 3 , further comprising building a consensus sequence for each cluster to produce a collection of consensus sequences.

5 . The method of claim 4 , wherein the collection of consensus sequences is used to determine the diversity of the immune repertoire.

6 . The method of claim 1 , wherein the molecular tag is an oligomer.

5 . The method of claim 6 , wherein the oligomer is at least a 9mer.

7 . The method of claim 1 , wherein the biological sample is blood or a fraction thereof.

8 . The method of claim 7 , wherein the blood is peripheral whole blood.

9 . The method of claim 7 , wherein the blood fraction comprises peripheral blood mononuclear cells.

10 . The method of claim 7 , wherein the blood sample is sorted based upon extracellular or intracellular markers.

11 . The method of claim 1 , wherein the immunoglobulin chain is the heavy chain or the light chain.

12 . The method of claim 11 , wherein immunoglobulin heavy chain comprise the immunoglobulin VDJ and constant regions.

13 . The method of claim 1 , wherein the TCR chain is the alpha chain, the beta chain, the gamma chain or the delta chain.

14 . The method of claim 13 , wherein the TCR chain comprises the VJ and constant regions.

Assignments (2)
SECURITY INTEREST Recorded Jan 31, 2018
From: LINEAGE BIOSCIENCES, INC.
To: BANK OF MONTREAL
Reel/Frame 044784/0836 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2017
From: IMMUMETRIX, INC.
To: LINEAGE BIOSCIENCES, INC.
Reel/Frame 041607/0926 →